OCRELIZUMAB AND HYALURONIDASE-OCSQ | B761371 | GENENTECH INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Sep. 13, 2036 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12421299(manufacturing) · relevance 85/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 800 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.